首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Mutation -538 T/C in bone morphogenetic protein 4 do not increase the risk in sickle-cell disease with orthopedic complications but strongly associated with increased LDH and uric acid level in Indian patients from Chhattisgarh and Jharkhand states.
【24h】

Mutation -538 T/C in bone morphogenetic protein 4 do not increase the risk in sickle-cell disease with orthopedic complications but strongly associated with increased LDH and uric acid level in Indian patients from Chhattisgarh and Jharkhand states.

机译:恰蒂斯加尔邦和贾坎德邦州印度裔患者中,骨形态发生蛋白4突变-538 T / C不会增加镰状细胞病伴骨科并发症的风险,但与LDH和尿酸水平升高密切相关。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Bone morphogenetic protein (BMP) are involved in the various orthopedic complications such as avascular necrosis, osteonecrosis and bone turnover, therefore genes coding for proteins, like BMP4, can be potential candidate for studying orthopedic disorders. METHODS: A case-control study was conducted to examine the association between SNP T538C of BMP4 and orthopedic complications in sickling patients by employing PCR-RFLP. RESULTS: A total of 200 cases and 172 control groups were studied from Indian population. T538C SNP has not been implicated in disease and doesn't increase the risk (OR=0.89, OR=0.68). We observed no significant association between the T538C polymorphism and case group in the studied population. However, we observed significantly increased uric acid and LDH level in homowild (TT), heteromutant (TC) and homomutant (CC) in case group compared to control group ( all p=0.0001) and (p=0.0001, p=0.0001, p=0.015 and p=0.0001, p=0.0001, p=0.0001 respectively) in the studied population. CONCLUSIONS: The T/C polymorphism in BMP4 is not associated with case group and in view of present observation, we suggest that evaluation of LDH and uric acid level and its association with polymorphisms in the BMP4 may be considered to be reliable molecular and biochemical markers, and possess promising rational for diagnostic potential in clinical cases.
机译:背景:骨形态发生蛋白(BMP)涉及各种骨科并发症,例如无血管坏死,骨坏死和骨转换,因此编码蛋白质的基因(如BMP4)可能是研究骨科疾病的潜在候选者。方法:采用病例对照研究,采用PCR-RFLP技术检测镰刀病患者BMP4的SNP T538C与骨科并发症之间的关系。结果:共研究了200例印度人和172个对照组。 T538C SNP尚未涉及疾病,也未增加风险(OR = 0.89,OR = 0.68)。我们没有观察到T538C基因多态性与病例组之间的显着关联。然而,与对照组相比,病例组同种野生型(TT),异种突变体(TC)和同种突变体(CC)的尿酸和LDH水平显着升高(所有p = 0.0001)和(p = 0.0001,p = 0.0001,p分别为0.015和p = 0.0001,p = 0.0001,p = 0.0001)。结论:BMP4中的T / C多态性与病例组无关,鉴于目前的观察,我们建议评估LDH和尿酸水平及其与BMP4中多态性的相关性可以认为是可靠的分子和生化标记,并具有在临床病例中诊断潜力的有希望的理由。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号